Cover Image

Detailed Analysis of Immune Tolerance Mechanisms to SARS-CoV-2 in Children Is Needed

Saved in:

Bibliographic Details
Main Author:	Hiroshi Ehara (Author)
Format:	Book
Published:	Frontiers Media S.A., 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

The devil is in the details: emerging insights on the relevance of wastewater surveillance for SARS-CoV-2 to public health
by: Steve E. Hrudey, et al.
Published: (2022)

Role of innate immunity in SARS-CoV-2 infection
by: Zihao Wang, et al.
Published: (2023)

An update on SARS-CoV-2 immunization and future directions
by: Rashmi Rana, et al.
Published: (2023)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

Innate immune recognition against SARS-CoV-2
by: Taisho Yamada, et al.
Published: (2023)

Immune Dysregulation in Acute SARS-CoV-2 Infection
by: Lauren Grimm, et al.
Published: (2023)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
by: Massimiliano Di Filippo, et al.
Published: (2022)

Immunopathological mechanisms involved in SARS-CoV-2 infection
by: Sávio Breno P. Brito, et al.
Published: (2020)

Factors associated with elevated SARS-CoV-2 immune response in children and adolescents
by: Sarah E. Messiah, et al.
Published: (2024)

Immune response to SARS‐CoV‐2 in children: A review of the current knowledge
by: Filippos Filippatos, et al.
Published: (2021)

Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection
by: Mario Dioguardi, et al.
Published: (2021)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients
by: Sandra Hasmann, et al.
Published: (2021)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
by: Sarah R. Leist, et al.
Published: (2020)

Current understanding of T cell immunity against SARS-CoV-2
by: Xiuyuan Lu, et al.
Published: (2022)

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs
by: Wu Zhong, et al.
Published: (2022)

SARS-CoV-2 and the Gastrointestinal Tract in Children
by: Maria Giovanna Puoti, et al.
Published: (2021)

Advancement of SARS-CoV-2 infection in children
by: Jacek Tabarkiewicz, et al.
Published: (2021)

Severe immune thrombocytopenic purple in children critical of SARS-CoV-2: Case report
by: Jesus Dominguez Rojas, et al.
Published: (2021)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

The effects of the SARS-CoV-2 pandemic on children and youth with special health care needs
by: Mel Michaud, et al.
Published: (2023)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Immune‐viral dynamics modeling for SARS‐CoV‐2 drug development
by: Youfang Cao, et al.
Published: (2021)

SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
by: Patrida Rangchaikul, et al.
Published: (2021)

Epigenetic Diet to Modulate Immune Response against SARS-CoV-2
by: Andika, et al.
Published: (2020)

Role of IFN and Complements System: Innate Immunity in SARS-CoV-2
by: Shibabaw T, et al.
Published: (2020)

Humoral immunity for durable control of SARS-CoV-2 and its variants
by: Ryutaro Kotaki, et al.
Published: (2023)

Dentists' Perceptions of Their SARS-CoV-2 Risk and Infection Control Needs
by: Leonor Sánchez-Pérez, et al.
Published: (2022)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020)

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
by: Wu Zhong, et al.
Published: (2022)

Evidence for Recombination as an Evolutionary Mechanism in Coronaviruses: Is SARS-CoV-2 an Exception?
by: Zisis Kozlakidis
Published: (2022)

SARS-CoV-2 and the nervous system: review on pathogenesis of nervous system SARS-CoV-2 damage
by: Bai, Francesca
Published: (2021)

SARS-CoV-2 induced IgA vasculitis confirmed with SARS-CoV-2 tissue testing
by: Ahmed N. Ansari, MD, et al.
Published: (2024)

Prevalence of SARS-CoV-2 in newborns born to SARS-CoV-2-positive mothers at 2 weeks of life
by: Sophia Jan, et al.
Published: (2024)

Pay attention to SARS‐CoV‐2 infection in children
by: Zhengde Xie
Published: (2020)

SARS-CoV-2 Vaccination for Children-An Open Issue
by: Désirée Caselli, et al.
Published: (2021)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020)

Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
by: Eman Alefishat, et al.
Published: (2022)

Update on SARS-CoV-2: Pathogenesis, Immunity, Treatment Protocol and Vaccines in Perspective
by: K M Vidya
Published: (2020)